Nuveen Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.44M | Hold |
65,851
| – | – | ﹤0.01% | 2527 |
|
|
2024
Q3 | $1.8M | Sell |
65,851
-20,920
| -24% | -$573K | ﹤0.01% | 2465 |
|
|
2024
Q2 | $2.25M | Buy |
+86,771
| New | +$2.25M | ﹤0.01% | 2326 |
|
|
2022
Q2 | – | Sell |
-4,417
| Closed | -$238K | – | 3278 |
|
|
2022
Q1 | $238K | Hold |
4,417
| – | – | ﹤0.01% | 3158 |
|
|
2021
Q4 | $339K | Sell |
4,417
-1,168
| -21% | -$89.6K | ﹤0.01% | 3154 |
|
|
2021
Q3 | $697K | Buy |
5,585
+81
| +1% | +$10.1K | ﹤0.01% | 3103 |
|
|
2021
Q2 | $861K | Sell |
5,504
-3,059
| -36% | -$479K | ﹤0.01% | 3058 |
|
|
2021
Q1 | $1.62M | Sell |
8,563
-416
| -5% | -$78.8K | ﹤0.01% | 2710 |
|
|
2020
Q4 | $1.13M | Buy |
8,979
+949
| +12% | +$119K | ﹤0.01% | 2757 |
|
|
2020
Q3 | $873K | Buy |
8,030
+3,938
| +96% | +$428K | ﹤0.01% | 2741 |
|
|
2020
Q2 | $492K | Sell |
4,092
-134
| -3% | -$16.1K | ﹤0.01% | 2903 |
|
|
2020
Q1 | $425K | Buy |
4,226
+1,004
| +31% | +$101K | ﹤0.01% | 2822 |
|
|
2019
Q4 | $782K | Sell |
3,222
-104
| -3% | -$25.2K | ﹤0.01% | 2774 |
|
|
2019
Q3 | $546K | Hold |
3,326
| – | – | ﹤0.01% | 2916 |
|
|
2019
Q2 | $785K | Buy |
+3,326
| New | +$785K | ﹤0.01% | 2827 |
|